Cementos Bio-B (CEMENTOS)

Santiago

Currency in CLP

1,395.00

0.00(0.00%)

Closed06/12

Fair Value

Day's Range

1,395.00

1,395.00

52 wk Range

650.00

1,450.00

CEMENTOS Income Statement

Featured here, the Income Statement (earnings report) for Cementos Bio-B, showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).

Advanced Income Statement

Period Ending:

2014

31/12

2015

31/12

2016

31/12

2017

31/12

2018

31/12

2019

31/12

2020

31/12

2021

31/12

2022

31/12

2023

31/12

Total Revenues

268,613.71

242,585.82

289,468.17

334,004.08

348,984.34

Total Revenues Growth

+2.3%

-9.69%

+19.33%

+15.39%

+4.49%

Cost Of Revenues

158,919.37

146,484.07

186,287.27

228,479.01

219,384.22

Gross Profit

109,694.35

96,101.75

103,180.9

105,525.06

129,600.13

Gross Profit Growth

+9.23%

-12.39%

+7.37%

+2.27%

+22.81%

Gross Profit Margin %

40.84%

39.62%

35.64%

31.59%

37.14%

Other Operating Expenses, Total

89,737.71

73,039.3

86,095.15

94,109.96

94,713.17

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+14.22%	-18.61%	+17.88%	+9.31%	+0.64%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	89,737.71	73,039.3	86,095.15	94,109.96	94,713.17
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-

Operating Income

19,956.63

23,062.45

17,085.75

11,415.1

34,886.96

Operating Income Growth

-8.71%

+15.56%

-25.92%

-33.19%

+205.62%

EBIT Margin %

7.43%

9.51%

5.9%

3.42%

10%

Net Interest Expenses

-5,041.8

-3,752.75

-2,962.46

-10,077.92

-13,142.92

Net Interest Expenses Growth

+8.84%

+25.57%

+21.06%

-240.19%

-30.41%

Interest Expense, Total

-5,965.16

-4,037.97

-3,561.45

-11,141.15

-14,352.87

Interest And Investment Income

923.36

285.22

598.99

1,063.23

1,209.96

Other Non Operating Expenses, Total

724.29

-862.37

3,538.92

642.49

4,008.02

EBT, Excl. Unusual Items

15,639.12

18,447.33

17,662.21

1,979.67

25,752.07

Gain (Loss) On Sale Of Assets

745.46

1,177.58

8,655.33

3,427.47

556.51

Other Unusual Items, Total

-1,340.95

-3,362.22

7,593.23

228.16

313.05

EBT, Incl. Unusual Items

15,043.64

16,262.69

33,910.77

5,635.3

26,621.63

EBT, Incl. Unusual Items Growth

-31.26%

+8.1%

+108.52%

-83.38%

+372.41%

EBT, Incl. Unusual Items Margin

5.6%

6.7%

11.71%

1.69%

7.63%

Income Tax Expense

2,094.91

2,350.53

6,884.93

-4,925.8

3,812.26

Net Income to Company

12,948.72

13,912.15

27,025.84

10,561.1

22,809.37

Minority Interest

155.2

-149.47

-146.9

-1.13

-12.25

Net Income

13,103.92

13,762.69

26,878.94

10,559.96

22,797.12

Net Income Growth

-33.73%

+5.03%

+95.3%

-60.71%

+115.88%

Net Income Margin %

4.88%

5.67%

9.29%

3.16%

6.53%

Preferred Dividend and Other Adjustments

-

-

-

-

-

Net Income to Common Excl. Extra Items

13,103.92

13,762.69

26,878.94

10,559.96

22,797.12

Basic EPS - Continuing Operations

49.59

52.09

101.73

39.97

86.28

Basic EPS - Continuing Operations Growth

-33.73%

+5.03%

+95.3%

-60.71%

+115.88%

Diluted EPS - Continuing Operations

49.59

52.09

101.73

39.97

86.28

Diluted EPS - Continuing Operations Growth

-33.73%

+5.03%

+95.3%

-60.71%

+115.88%

Basic Weighted Average Shares Outstanding

264.22

264.22

264.22

264.22

264.22

Diluted Weighted Average Shares Outstanding

264.22

264.22

264.22

264.22

264.22

Dividend Per Share

16

42

48

12

36

Dividend Per Share Growth

-56.76%

+162.5%

+14.29%

-75%

+200%

EBITDA

30,632.69

34,832.07

30,270.03

24,159.49

48,081.59

EBITDA Growth

-7.01%

+13.71%

-13.1%

-20.19%

+99.02%

EBITDA Margin %

11.4%

14.36%

10.46%

7.23%

13.78%

EBIT